Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

Is that the case? Let's look into it and decide whether the company is worth investing in.

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best mid cap stocks to buy according to hedge funds.

In a Q&A, Recursion’s incoming CEO acknowledges hype around the idea of using AI to expedite drug development, and says it's ...

Welcome to this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is slated to report third-quarter 2025 results on Nov. 5, before the opening bell.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

On October 29, 2025, in Java, Indonesia, @resepherey shared a funny video capturing an unexpected mishap during a shared mealtime. In the video, a group of friends is enjoying a meal together in a hut ...

Mount Sumbing stands high above Central Java’s countryside, where volcanic soil supports generations of stepped farming traditions. Catanduanes under Signal No. 4 as Uwan intensifies This one decision ...